|
2018
|
Invention
|
Enzyme compositions with reduced viral and microbial contamination. The present invention pertain... |
|
2017
|
Invention
|
Method for detection of ischemic strokes.
The present invention relates to the identification an... |
|
2015
|
Invention
|
Processes for producing compositions with improved safety profile comprising pancreatin and compo... |
|
2014
|
Invention
|
Human antibodies that bind human il-12 and methods for producing.
Human antibodies, preferably r... |
|
2013
|
Invention
|
Methods for extruding powdered nutritional products using a high shear element. A method of produ... |
|
|
Invention
|
Methods for extruding powered nutritional products using a high shear element. A method of produc... |
|
|
Invention
|
Methods of prognosis and diagnosis of sepsis. Provided are methods of diagnosing sepsis in a pati... |
|
|
Invention
|
Extruded nutritional powders having improved emulsion stability and dispersibility and methods of... |
|
|
Invention
|
Use of extrusion methods to improve heat labile vitamin stability. Extruded nutritional powders a... |
|
2012
|
Invention
|
Novel carboxylic acid derivatives, their preparation and use.
Carboxylic acid derivatives
Carb... |
|
|
Invention
|
Novel inhibitor compounds of phosphodiesterase type 10a.
The present invention relates to novel ... |
|
2011
|
Invention
|
Solid retard formulations based on solid dispersions. A formulation comprising a melt-processed s... |
|
|
Invention
|
Tnf-α binding proteins. TNF-α binding proteins, including chimeric, CDR-grafted, and humanized an... |
|
|
Invention
|
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating ... |
|
|
Invention
|
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modu... |
|
|
Invention
|
Curcuminoid solid dispersion formulation.
A curcuminoid formulation, comprising a melt-processed... |
|
|
Invention
|
Curcuminoid solid dispersion formulation. A curcuminoid formulation, comprising a melt-processed ... |
|
|
Invention
|
Melt-extruded solid dispersions containing an apoptosis-inducing agent. A pro-apoptotic solid dis... |
|
|
Invention
|
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors. The present invent... |
|
|
Invention
|
Amyloid-beta binding proteins. The present invention relates to amyloid-beta (Αβ) binding protein... |
|
|
Invention
|
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy... |
|
|
Invention
|
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy. T... |
|
|
Invention
|
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in t... |
|
|
Invention
|
Method for detection of ischemic strokes. The disclosure provides a method of aiding in the diagn... |
|
|
Invention
|
Method for detection of ischemic strokes. The present invention relates to the identification and... |
|
|
Invention
|
Nanosuspension formulation comprising a polydimethylsiloxane hydrophobic phase. A nanosuspension ... |
|
|
Invention
|
Amyloid-beta binding proteins. The present invention relates to amyloid-beta (As) binding protein... |
|
|
Invention
|
Method and device for determining mechanical stress load and interface effects on particles dispe... |
|
|
Invention
|
Test solvent for evaluating the compatibility of biologically active substances and graft copolym... |
|
|
Invention
|
Method for evaluating the solubility of a crystalline substance in a polymer. A method for evalua... |
|
2010
|
Invention
|
Carboxamide compounds and their use as calpain inhibitors. The present invention relates to novel... |
|
|
Invention
|
Carboxamide compounds and their use as calpain inhibitors iv. The present invention relates to no... |
|
|
Invention
|
Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber l... |
|
|
Invention
|
Abuse resistant melt extruded formulation having reduced alcohol interaction. The present inventi... |
|
|
Invention
|
Modulators of 5-ht receptors and methods of use thereof. The present application relates to aryl-... |
|
|
Invention
|
Delivery system for sustained release of a calcium -channel blocking agent. A delivery system for... |
|
|
Invention
|
Methods for treating psoriasis. The invention provides methods of treating psoriasis in a subject... |
|
|
Invention
|
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the ... |
|
|
Invention
|
Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl... |
|
|
Invention
|
Use of substituted oxindole derivatives for the treatment and prophylaxis of pain. The present in... |
|
|
Invention
|
Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor. The invention rel... |
|
|
Invention
|
Formulation for oral administration of apoptosis promoter.
An orally deliverable pharmaceutical ... |
|
1996
|
P/S
|
Produits pharmaceutiques et vétérinaires. |
|
1995
|
P/S
|
Produits pharmaceutiques, produits chimiques pour l'hygiène,
produits diététiques pour la médeci... |
|
1975
|
P/S
|
Pharmaceutical and veterinary products. |
|
|
P/S
|
Produits pharmaceutiques, c'est-à-dire médicaments. |
